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Abstract. 
 
At mitosis, focal adhesions disassemble and 
the signal transduction from focal adhesions is inacti-
vated. We have found that components of focal adhe-
sions including focal adhesion kinase (FAK), paxillin, 
 
and p130
 
CAS
 
 (CAS) are serine/threonine phosphory-
lated during mitosis when all three proteins are tyrosine 
dephosphorylated. Mitosis-specific phosphorylation 
continues past cytokinesis and is reversed during post-
mitotic cell spreading.
We have found two significant alterations in FAK-
mediated signal transduction during mitosis. First, the 
association of FAK with CAS or c-Src is greatly inhib-
ited, with levels decreasing to 16 and 13% of the inter-
phase levels, respectively. Second, mitotic FAK shows 
decreased binding to a peptide mimicking the cytoplas-
mic domain of beta-integrin when compared with FAK 
of interphase cells. Mitosis-specific phosphorylation is 
responsible for the disruption of FAK/CAS binding be-
cause dephosphorylation of mitotic FAK in vitro by 
protein serine/threonine phosphatase 1 restores the 
ability of FAK to associate with CAS, though not with 
c-Src. These results suggest that mitosis-specific modifi-
cation of FAK uncouples signal transduction pathways 
involving integrin, CAS, and c-Src, and may maintain 
FAK in an inactive state until post-mitotic spreading.
Key words: FAK ¥ CAS ¥ paxillin ¥ mitosis ¥ phos-
phorylation ¥ c-Src
 
Burridge and Chrzanowska-Wodnicka, 1996; Craig and
Johnson, 1996). They are specialized sites that link the ex-
tracellular matrix and the actin cytoskeleton. Since bun-
dles of actin filaments (stress fibers) are anchored to focal
adhesions, focal adhesions regulate the organization of
stress fibers, thereby controlling cell morphology. In addi-
tion to this structural role, focal adhesions are involved in
integrin-mediated signal transduction. This is evident from
the fact that focal adhesions contain a variety of enzymes
involved in signal transduction including protein kinase
C, tyrosine kinases, and tyrosine phosphatases (Rohr-
schneider, 1980; Hanks et al., 1992; Schaller et al., 1992;
Liao and Jaken, 1993; Serra-Pages et al., 1995; Shen et al.,
1998). Thus, the loss of adhesion during mitosis should not
only lead to the disassembly of focal adhesions, but also
cause inactivation of integrin-mediated signal transduc-
tion. While the importance of the modulation of focal
adhesion activities in synchrony with the cell cycle is rec-
ognized, little is known regarding the mechanisms respon-
sible for the alterations in these activities during mitosis
and post-mitotic spreading. Although mitotic cells and
trypsinized cells are both rounded with disassembled focal
adhesions and stress fibers, they are clearly different in
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1.
 
 Abbreviations used in this paper:
 
 CAS, p130
 
CAS
 
; ECM, extracellular ma-
trix; FAK, focal adhesion kinase; PP1, protein phosphatase 1.
 
D
 
URING
 
 mitosis, normal adherent cells show massive
changes in their adhesive interactions with the ex-
tracellular matrix (ECM).
 
1
 
 During prophase, cells
round up and lose attachments to a substrate. After cyto-
kinesis, cells start to reattach and spread. The attachment
to the substrate during early G1 phase is essential for cells
to pass through the restriction point at each cell cycle
(OÕNeill et al., 1986), indicating that cell adhesion trans-
mits a signal for cell cycle progression. The cycle of attach-
ment and detachment during the cell cycle is thus critical
to proliferation of normal adherent cells.
Focal adhesions are responsible for the cell-substrate
 
adhesion of fibroblasts and other adhesive animal cells (re-
viewed in Schaller and Parsons, 1994; Jockusch et al., 1995; 
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terms of their responsiveness to ECM. Trypsinized cells
immediately begin to reattach and spread when replated
on ECM-coated substrates, focal adhesions are reassem-
bled, and certain signals are transduced to allow cell
spreading and proliferation. In contrast, mitotic cells stay
detached until the completion of cytokinesis, even if they
are placed on ECM. There must be distinctive mechanisms
in mitotic cells that suppress the formation of focal adhe-
sions and inhibit signal transduction.
Focal adhesion kinase (FAK) appears to be a primary
mediator of integrin-mediated signal transduction (re-
viewed in Parsons et al., 1994; Schaller and Parsons, 1994;
Richardson and Parsons, 1995; Hanks and Polte, 1997).
FAK is a tyrosine kinase prominently localized at focal ad-
hesions (Hanks et al., 1992; Schaller et al., 1992), and ty-
rosine phosphorylated FAK binds to the SH2 domains of
Src (Schaller et al., 1994; Xing et al., 1994; Eide et al., 1995;
Schlaepfer et al., 1997) and Grb2 (Schlaepfer et al., 1994,
1997). In addition, FAK is known to bind to a variety of
other signaling proteins, including paxillin (Turner and
Miller, 1994; Tachibana et al., 1995), PI-3 kinase (Chen
and Guan, 1994; Bachelot et al., 1996; Chen et al., 1996;
Saito et al., 1996), p130
 
CAS
 
 (CAS) (Polte and Hanks, 1995,
1997; Harte et al., 1996), talin (Chen et al., 1995), and the
cytoplasmic domain of integrin beta subunit (Schaller et al.,
1995). Among these FAK-associated proteins, both paxil-
lin and CAS are considered as nonenzymatic ÒdockingÓ
proteins (Sakai et al., 1994; Turner, 1994; Turner and
Miller, 1994; Burnham et al., 1996; Nojima et al., 1996;
Vuori et al., 1996; Klemke et al., 1998). Paxillin is phos-
phorylated at tyrosine residues during integrin-mediated
cell attachment and binds to vinculin, FAK, and Crk
(Burridge et al., 1992; Birge et al., 1993; Turner, 1994;
Turner and Miller, 1994; Wood et al., 1994; Hildebrand et al.,
1995; Schaller and Parsons, 1995; Tachibana et al., 1995).
CAS binds to FAK via its SH3 domain (Polte and Hanks,
1995, 1997; Harte et al., 1996), and is also known to associ-
ate with other signal transduction molecules, including Src,
Crk (Sakai et al., 1994; Petch et al., 1995; Burnham et al.,
1996; Nakamoto et al., 1996), and PTP1B (Liu et al., 1996).
It is further suggested that the association of Src with ei-
ther CAS or FAK leads to the activation of Src (Hanks
and Polte, 1997). Thus, FAK, CAS, and paxillin are likely
to play a central role in signal transduction mediated via
focal adhesions.
In this report we investigated possible mechanisms un-
derlying mitosis-induced focal adhesion disassembly and
inactivation of integrin-mediated signaling. We found that
FAK, paxillin, and CAS each become prominently phos-
phorylated on serine and/or threonine residues in a mito-
sis-specific fashion, coincident with their becoming de-
phosphorylated on tyrosine. We also found that the FAK/
CAS/c-Src signaling complex is dissociated during mitosis.
While FAK tyrosine dephosphorylation appears to disrupt
the FAK/c-Src interaction, we found that the FAK/CAS
dissociation is due to mitosis-specific serine phosphoryla-
tion of FAK. We also observed that mitotic FAK shows
decreased binding to the cytoplasmic domain of integrin
beta subunit. Our findings suggest that mitosis-specific
phosphorylation of FAK and other focal adhesion compo-
nents contributes to the arrest of integrin-associated sig-
naling activities during mitosis.
 
Materials and Methods
 
Cell Culture
 
SV-40 transformed rat embryo cells (REF-2A) were maintained in DME
containing 10% newborn calf serum (NCS) in an atmosphere of 5% CO
 
2
 
and 95% air at 37
 
8
 
C. REF-2A cells showed anchorage dependence for cell
growth, and exhibited stress fibers and focal adhesions. Balb/C/3T3 cells
and HeLa cells were maintained in DME containing 10% calf serum.
 
Preparation of Cells and Synchronization for
Cell Division
 
Mitotic cells were prepared as described in Yamashiro et al. (1990).
Briefly, 6Ð10 large dishes (245 
 
3
 
 245 mm; Nalge Nunc International) of
REF-2A cells (subconfluent) were treated for 3 h with 0.25 
 
m
 
g/ml nocoda-
zole, and collected by the shake-off method. In some experiments, mitotic
cells were collected by the shake-off method without treatment of nocoda-
zole. Trypsinized cells were prepared from one large dish (245 
 
3
 
 245 mm)
by incubation with trypsin (0.05% trypsin and 2 mM EDTA in PBS), fol-
lowed by inactivation of trypsin with the addition of 3% BSA and 0.5 mg/
ml of soybean trypsin inhibitor. Trypsinized cells were collected and incu-
bated for 30 min in DME containing 1% NCS before harvest. Inter-
phase cells were also collected from one large dish (245 
 
3
 
 245 mm).
Cells at later stages of cell division (such as cytokinesis or post-mitotic
cell spreading) were prepared as described in Hosoya et al. (1993).
Briefly, cells were first treated for 3 h with 0.25 
 
m
 
g/ml nocodazole, and mi-
totic cells were collected (prometaphase). After being washed with cold
DME to remove nocodazole, cells were plated into fresh culture dishes,
and incubated at 37
 
8
 
C in DME containing 10% NCS to allow cell cycle
progression. Cell morphologies at different mitotic stages were checked
by phase-contrast light microscopy. As reported previously (Hosoya et al.,
1993), these cells show synchronized cell division in a reasonably short
time window. Mitotic cells recovered spindles after 10Ð20 min of incuba-
tion following release of nocodazole arrest, and underwent cytokinesis at
40Ð60 min. Post-mitotic cell spreading occurred in 80Ð180 min, at which
time both stress fibers and focal adhesions were reassembled. Mitotic 3T3
and HeLa cells were also prepared as above.
In some experiments, REF-2A cells at mitosis were labeled with 
 
32
 
P-
orthophosphoric acid as described previously (Yamashiro et al., 1990;
Hosoya et al., 1993). Briefly, cells were incubated for 3 h in phosphate-
free DME containing 10% dialyzed NCS, 0.25 
 
m
 
g/ml nocodazole, and
0.125 mCi/ml 
 
32
 
P-orthophosphoric acid and mitotic cells were collected.
Interphase cells were labeled in the same way except that nocodazole was
omitted.
 
Immunoprecipitation
 
Immunoprecipitation was performed under the following three condi-
tions. We found that FAK immunoprecipitates prepared under condition
II gave consistent results in examination of FAK-associated proteins in-
cluding CAS, c-Src, paxillin, and talin.
 
Condition I. 
 
Cells at different stages of mitosis were solubilized in
buffer I (10 mM Tris-Cl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5%
NP-40, 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium vanadate, 20 mM
NaF, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, and 0.2 mM PMSF), and
stored in a 
 
2
 
80
 
8
 
C freezer. After being thawed quickly, the lysates were
homogenized by several passes through a 25-gauge needle, and centri-
fuged at 100,000 
 
g
 
 for 15 min. 2Ð3 
 
m
 
g of mouse mAb against FAK, paxillin
(Transduction Laboratories), or rabbit polyclonal antibody (pAb) against
FAK or CAS (Santa Cruz Biotechnology, Inc.) was added to the superna-
tants. After incubation at 4
 
8
 
C for 1.5 h, protein AÐSepharose-conjugated
rabbit antibody against mouse IgG (for mAb) or protein AÐSepharose
(for pAb) was added, and incubation continued for 1 h. After extensive
washing with buffer I, the immunocomplexes were analyzed by SDS-
PAGE, followed by immunoblotting.
 
Condition II. 
 
Cells were lysed with buffer II (50 mM Hepes, 150 mM
NaCl, 10% glycerol, 1.5 mM MgCl
 
2
 
, 1 mM EGTA, 1% Triton X-100, 10
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, 1 mM PMSF, 25 mM NaF, 1 mM so-
dium vanadate, and 50 mM beta-glycerophosphate), and homogenized by
a Dounce homogenizer. After centrifugation at 16,000 
 
g
 
 for 20 min, the
cell extracts (made to an equal protein concentration of 5Ð10 mg/ml) were
incubated with rabbit pAb against the COOH-terminal peptides of FAK
or CAS (Santa Cruz Biotechnology, Inc.) or mouse mAb against paxillin
(Transduction Laboratories), followed by incubation with protein AÐSeph- 
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arose beads (Pharmacia). The immunocomplexes were washed three
times with buffer II, analyzed by SDS-PAGE, followed by immunoblot-
ting. In some experiments, protein AÐconjugated primary antibodies were
used.
 
Condition III. 
 
Cells were lysed in buffer III (50 mM Tris-Cl, pH 7.4, 150
mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.05% SDS, 0.5% sodium
deoxycholate, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, 1 mM PMSF, 25 mM
NaF, 1 mM sodium vanadate, and 50 mM beta-glycerophosphate), and
processed as described for condition II.
 
Immunoblotting
 
The following antibodies were used for immunoblotting: antibodies
against FAK (mAb, Transduction Laboratories; pAb, Santa Cruz Bio-
technology, Inc.), paxillin (Transduction Laboratories), phosphotyrosine
(PY20; Transduction Laboratories), CAS (Transduction Laboratories),
PI-3 kinase (Transduction Laboratories), c-Src (mAb; Upstate Biotech-
nology; pAb, Santa Cruz Biotechnology, Inc.), Crk (Santa Cruz Biotech-
nology, Inc.), cyclin B1 (Oncogene Science, Inc.), and talin (Sigma Chem-
ical Co.). For preparation of total cell lysates, cells at different stages of
mitosis were lysed in 2
 
3
 
 SDS-PAGE sample buffer. The equivalent
amounts of total proteins were separated by SDS-PAGE, transferred to
PVDF membranes, and analyzed by immunoblotting with the indicated
antibodies. FAK immunoprecipitates were separated by SDS-PAGE, and
analyzed by immunoblotting with the antibodies against FAK, CAS,
c-Src, and phosphotyrosine. The blots were quantitated by densitometry
to determine levels of FAK, CAS, c-Src, and phosphotyrosine. The levels
of CAS, c-Src, and phosphotyrosine were normalized by the levels of FAK
immunoprecipitate. The association of CAS and c-Src, as well as FAK
phosphotyrosine levels, from mitotic and trypsinized cells was expressed
by ratios to those of interphase FAK.
To determine the level of phosphotyrosine, immunoprecipitates of
FAK, paxillin, or CAS were separated on SDS gels, and each was trans-
ferred to PVDF membranes. The membranes were first immunoblotted
with antiphosphotyrosine antibody (PY20; Transduction Laboratories).
After removal of the PY20 antibody, the same membrane blots of paxillin,
FAK, and CAS immunoprecipitates were stripped and reprobed with
anti-FAK, antipaxillin, and anti-CAS antibodies, respectively. The blots
were quantitated by densitometry to determine ratios of phosphotyrosine
levels divided by the levels of FAK, paxillin, and CAS.
 
Protein Phosphatase Treatment
 
FAK, paxillin, and CAS were immunoprecipitated under condition I from
mitotic and interphase cells using specific antibodies, and half of the im-
munoprecipitates were treated for 30 min at 30
 
8
 
C with one unit of recom-
binant serine/threonine phosphatase (PP1, 
 
a
 
-isoform from rabbit muscle;
Calbiochem-Novabiochem Corp.) in 50 mM imidazole buffer, pH 7.0,
containing 0.25 mM MnCl
 
2
 
, 5 mM DTT, 100 mM KCl, 2 mM MgCl
 
2
 
, and
0.2 mg/ml BSA. Under this condition, no tyrosine dephosphorylation was
observed. Both treated and untreated samples were separated by SDS-
PAGE, followed by immunoblotting with anti-FAK (Transduction Labo-
ratories), antipaxillin (Transduction Laboratories), and anti-CAS (Trans-
duction Laboratories) antibodies to examine changes in mobility shifts.
 
Reconstitution of a FAK/CAS Complex
 
The reconstitution of a FAK/CAS complex was performed by incubating
FAK immunoprecipitates with interphase extracts. First, FAK was immu-
noprecipitated from mitotic cells under condition I, and the immunocom-
plex was divided into three equal aliquots. The first was treated with PP1
as described above, while the second two were untreated. All three sam-
ples were washed extensively with the immunoprecipitation buffer II and
1 
 
m
 
g of the antigenic peptide (CNLLDVIDQARLKMLG) was added in
order to block the residual sites of FAK antibody. The PP1-treated sam-
ple and one untreated sample were incubated with an equivalent amount
of interphase extracts, which had been prepared by homogenization of in-
terphase cells in the immunoprecipitation buffer II, followed by centrifu-
gation at 16,000 
 
g
 
 for 20 min. The incubation with the interphase extracts
continued for 30 min at 4
 
8
 
C. The other untreated sample was incubated
with the immunoprecipitation buffer II alone. All three were again exten-
sively washed with the same buffer, washed once with PBS, and analyzed
by SDS-PAGE followed by Western blotting with antibodies against
FAK, CAS, and c-Src.
 
Binding of FAK to a Cytoplasmic Peptide of Integrin 
Beta Subunit
 
Binding of FAK or paxillin to a peptide (called SP1; CKLLMIIH-
DRREFA) was performed as described by Schaller et al. (1995) as SP1
represents a FAK binding site within the cytoplasmic tail of the integrin
beta subunit (Schaller et al., 1995). Briefly, varying concentrations (0.3Ð3
mg/ml) of the lysates of mitotic, interphase, or trypsinized cells were incu-
bated for 60 min at 4
 
8
 
C with beads which had been conjugated with the
SP1 peptide (Schaller et al., 1995). The beads were then washed five times
with the lysis buffer, and the bound proteins were solubilized with SDS
sample buffer, separated by SDS-PAGE, and analyzed by Western blot-
ting using anti-FAK or antipaxillin antibody.
 
FAK Kinase Assay
 
The kinase activity of FAK immunoprecipitates was measured using a
synthetic random co-polymer (GluTyr 
 
5
 
 4:1, Sigma Chemical Co.) as a
substrate. Immunoprecipitated FAK (under condition I or II) and the syn-
thetic peptide were incubated at 30
 
8
 
C in the kinase assay buffer (50 mM
Tris-HCl, pH 7.5, 10 mM MgCl
 
2
 
, 1 mM MnCl
 
2
 
, 0.1 mM ATP, and 2 
 
m
 
Ci of
gamma-[
 
32
 
P]ATP) for 20 min. The reaction mixtures were analyzed by
SDS-PAGE followed by autoradiography. The amounts of FAK in immu-
noprecipitates were normalized by immunoblotting with anti-FAK anti-
body. The activities were determined by either densitometry of autora-
diography or by measuring radioactivity of the phosphorylated co-polymer
using a PhosphorImager (Molecular Dynamics Inc.).
 
Far Western Blot Analysis
 
The SH2 domain of chicken c-Src (amino acid residues 148Ð251) was ex-
pressed as a glutathione-
 
S
 
-transferase (GST) fusion protein in 
 
Escherichia
coli
 
 and affinity purified by glutathioneÐagarose adsorption essentially as
described by Guan and Dixon (1991). The GST-SrcSH2 fusion protein
was used at 10 
 
m
 
g/ml to probe immunoprecipitated FAK immobilized on
nitrocellulose membrane as described by Hildebrand et al. (1995). GST-
SrcSH2 bound to FAK was detected by antibody against GST (1 
 
m
 
g/ml;
Sigma Chemical Co.) followed by ECL with HRP-conjugated protein A
(1:1,000; Amersham Life Science). The membrane was then stripped and
reprobed with anti-FAK antibody (0.2 
 
m
 
g/ml; Santa Cruz Biotechnology)
for normalization.
 
Other Procedures
 
SDS-PAGE was performed as described by Blatter et al. (1972) using
12.5% polyacrylamide, except the buffer system of Laemmli (1970) was
used. Phosphoamino-acid analysis was performed as described (Hunter
and Sefton, 1980). Protein concentrations were determined by the method
of Bradford (1976) using BSA as a standard.
 
Results
 
Serine Phosphorylation Is Responsible for
Mitosis-specific Mobility Shifts of FAK, CAS,
and Paxillin
 
We observed that FAK, CAS, and paxillin showed SDS-
PAGE mobility shifts during mitosis. FAK, CAS, and pax-
illin were immunoprecipitated under condition I from mi-
totic, interphase, or trypsinized cells, and immunoblotted
with specific antibodies. Fig. 1 shows all three proteins of
mitotic cells (lane M) showed slower mobilities than their
counterparts from interphase and trypsinized cells (lanes I
and T, respectively), indicating that these proteins are
modified specifically during mitosis. Essentially the same
mobility shifts were observed when these proteins were
immunoprecipitated under other conditions (II or III, data
not shown).
To test whether the mitotic modification is serine/threo-
nine phosphorylation, we examined the effect of phos-
phatase treatment on the mobility shifts. FAK, CAS, and 
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paxillin were again immunoprecipitated from mitotic and
interphase cells. One-half of each immunoprecipitate was
treated with serine/threonine protein phosphatase 1 (PP1),
and immunoblotted with specific antibodies. As Fig. 2 a
shows, PP1 treatment eliminated or greatly decreased the
mobility shifts shown by mitotic FAK, CAS, and paxillin,
indicating that serine/threonine phosphorylation is largely
responsible for the mobility shifts.
We then analyzed the tyrosine phosphorylation levels of
the three proteins during mitosis. FAK, CAS, and paxillin
were immunoprecipitated from mitotic and interphase
cells, and blotted with PY20. The same membranes were
reprobed with individual antibodies to confirm that ap-
proximately equal amounts of the proteins were immuno-
precipitated. As Fig. 2 b shows, interphase FAK, CAS,
and paxillin strongly reacted with PY20. In contrast, PY20
antibody did not detect mitotic FAK, CAS, and paxillin,
indicating that all three proteins were tyrosine dephos-
phorylated during mitosis. We further examined 
 
32
 
P incor-
poration of these proteins by immunoprecipitating mitotic
and interphase proteins from in vivo 
 
32
 
P-labeled cells, fol-
lowed by SDS-PAGE and autoradiography. As Fig. 2 c
shows, the levels of 
 
32
 
P incorporation were not markedly
increased during mitosis. This is because 
 
32
 
P incorporation
by mitotic serine/threonine phosphorylation was negated
by simultaneous tyrosine dephosphorylation.
 
Dissociation of FAK/CAS/c-Src Complex
during Mitosis
 
To explore the functional significance of mitosis-specific
phosphorylation of FAK, we examined whether the asso-
ciation between FAK and FAK-associated proteins (in-
cluding CAS, paxillin, c-Src, and talin) was altered. We
found that the levels of CAS and c-Src associated with
FAK immunoprecipitates were greatly reduced in mitotic
cells (Fig. 3 a). In contrast, similar levels of paxillin or talin
associated with FAK in mitotic or interphase cells were
found (data not shown). Quantitative analyses (Fig. 3 b)
reveal the levels of CAS or c-Src associated with mitotic
FAK are 16 
 
6
 
 9% and 13 
 
6
 
 10% of those associated with
interphase FAK. The difference is not due to the rounded
morphology of mitotic cells because FAK immunoprecipi-
tated from rounded trypsinized cells was associated with
considerable amounts of CAS and c-Src. The levels of
CAS and c-Src were 83 
 
6
 
 23% and 70 
 
6
 
 34% of the inter-
phase levels, respectively. The dissociation of FAK/CAS/
c-Src complex in mitotic cells is not due to nocodazole
Figure 1. Mitosis-specific modifica-
tion of CAS, FAK, and paxillin. CAS,
FAK, and paxillin (PAX) were immu-
noprecipitated under condition I from
trypsinized (lane T), mitotic (lane M),
and interphase (lane I) cells and immu-
noblotted with the specific antibodies
against each protein. All three proteins
show slower electrophoretic mobility
during mitosis, indicating that FAK,
CAS, and paxillin undergo mitosis-
specific modification.
Figure 2. Serine phosphorylation is responsible for the mobility
shifts. (a) Loss of mobility shifts by the treatment with PP1. FAK,
CAS, and paxillin (PAX) were immunoprecipitated under condi-
tion I from mitotic (odd numbered lanes) or from interphase
(even numbered lanes) cells, and half of the immunoprecipitates
(lanes 3, 4, 7, 8, 11, and 12) were treated with PP1 to dephos-
phorylate phosphoserine and phosphothreonine. Note that PP1
treatment eliminates or greatly decreases the mobility shifts
shown by mitotic FAK (compare lanes 1 and 3), CAS (compare
lanes 5 and 7), and paxillin (compare lanes 9 and 11). (b) Ty-
rosine dephosphorylation of FAK, CAS, and paxillin during mi-
tosis. FAK, CAS, and paxillin (PAX) were again immunoprecipi-
tated under condition I from mitotic (lanes M) and interphase
(lanes I) cells. The immunoprecipitates were first immunoblotted
with PY20 (top; lanes 1, 2, 5, 6, 9, and 10), and then reprobed with
FAK, CAS, and paxillin antibodies (bottom; lanes 3, 4, 7, 8, 11,
and 12). Note that PY20 reacts strongly with the immunoprecipi-
tates prepared from interphase but not from mitotic cells, indicat-
ing that mitotic FAK, CAS, and paxillin are dephosphorylated at
tyrosine residues. (c) Phosphate incorporation of FAK, CAS, and
paxillin. FAK, CAS, and paxillin were immunoprecipitated un-
der condition I from mitotic (lanes M) and interphase (lanes I)
cells that had been labeled in vivo with 32P inorganic phosphate.
The  32P-labeled immunoprecipitates were analyzed by SDS-
PAGE followed by autoradiography. The levels of 32P incorpora-
tion in mitotic FAK, CAS, and paxillin are not greatly increased
because serine phosphorylation is negated by tyrosine dephos-
phorylation. 
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treatment because similar dissociation was observed with
mitotic cells prepared without nocodazole treatment.
Differences in FAK phosphorylation among interphase,
mitotic and trypsinized cells were further compared using
phosphoamino-acid analysis and immunoblotting with the
PY20 antibody. Phosphoamino-acid analysis revealed that
FAK from both mitotic and trypsinized cells was tyrosine
dephosphorylated relative to interphase FAK (Fig. 3 c). In
addition, it showed that mitotic phosphorylation occurred
at serine residues but not at threonine residues. Immu-
noblots with PY20 also revealed that FAK from both
trypsinized and mitotic cells had greatly reduced levels of
phosphotyrosine when compared with interphase FAK
(Fig. 3 a, bottom panel). These results suggest that mitotic
Figure 3. Dissociation of a FAK/
CAS/c-Src complex during mito-
sis. (a) FAK was first immuno-
precipitated under condition II
from trypsinized (lane T), mi-
totic (lane M), and interphase
(lane I) cells, and analyzed by
immunoblotting with anti-FAK,
anti-CAS, and anti-c-Src. Phos-
photyrosine levels of immuno-
precipitated FAK were exam-
ined by PY20. Note that FAK
from mitotic cells showed much
reduced association with CAS or
c-Src. (b) Quantitative analyses
of the association of CAS and
c-Src with FAK, and phosphoty-
rosine levels of FAK immuno-
precipitated from trypsinized,
mitotic, and interphase cells. The
CAS and c-Src association as
well as FAK phosphotyrosine
levels were expressed as ratios to
those of interphase FAK. Data
were obtained from five inde-
pendent experiments. (c) Phos-
phoamino-acid analyses of FAK
immunoprecipitated from 32P-
labeled, interphase, mitotic, and
trypsinized cells. PS, phospho-
serine; PT, phosphothreonine;
PY, phosphotyrosine.
Figure 4. Reconstitution of a
FAK/CAS complex following
dephosphorylation of mitotic
FAK. (a) FAK was immunopre-
cipitated under condition I from
mitotic cells and divided into
three equal parts for further
treatment: lane 1, neither incu-
bated with interphase extracts
nor treated with PP1; lane 2, in-
cubated with interphase extracts
following treatment with PP1;
lane 3, incubated with interphase
extracts. After extensive wash-
ing, the association of FAK with
CAS was examined by blotting
with the anti-FAK antibody or
anti-CAS antibody. Phosphoty-
rosine levels of FAK were exam-
ined by PY20. For comparison,
FAK immunoprecipitates from
interphase cells were blotted with the same antibodies (lane 4). (b) Quantitative analyses. The CAS reassociation and phosphotyrosine
levels of FAK are expressed as ratios to those found in FAK incubated with interphase extracts but without prior PP1 treatment
(2PP1). Data were obtained from five independent experiments. 
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serine phosphorylation may be involved in the dissociation
of a FAK/CAS/c-Src complex during mitosis. However,
quantitative analysis revealed that FAK from trypsinized
cells reacted to PY20 to a greater extent than did mitotic
FAK; the levels of PY20 reactivity of FAK from tryp-
sinized and mitotic cells are 23 
 
6
 
 11% and 8 
 
6
 
 7% of the
level of interphase FAK, respectively (Fig. 3 b). Because
FAK is tyrosine phosphorylated at multiple sites (Schaller
and Parsons, 1994; Richardson and Parsons, 1995; Hanks
and Polte, 1997), a possibility remained that residual tyro-
sine phosphorylation of FAK in trypsinized cells would oc-
cur at critical sites, which may be sufficient to retain the
association of FAK with CAS or c-Src.
 
Mitotic Serine Phosphorylation Is Responsible for the 
Dissociation of FAK and CAS
 
To test whether mitosis-specific serine phosphorylation or
tyrosine dephosphorylation causes the disruption of the
FAK/CAS/c-Src complex, we dephosphorylated mitotic
FAK by PP1, and examined whether serine dephosphory-
lated FAK was able to reassociate with CAS or c-Src.
FAK was first immunoprecipitated from mitotic cells un-
der condition I. One-third of the immunoprecipitate was
used to confirm that neither CAS nor c-Src is associated
with mitotic FAK (lane 1 of Fig. 4 a). The rest of the im-
munoprecipitate was divided in half; one (lane 2) was de-
phosphorylated by PP1, and the other (lane 3) was un-
treated. Fig. 4 a shows PP1 treatment resulted in the loss
of mobility shift of FAK, confirming dephosphorylation of
mitotic FAK. Both PP1 treated and untreated FAK were
incubated with interphase extracts. After extensive wash-
ing, the binding of CAS or c-Src was examined by immu-
noblotting. Dephosphorylated FAK (Fig. 4 a, lane 2) was
able to reassociate with CAS of interphase extracts (sec-
ond panel). The level of CAS reassociation was compara-
ble to interphase FAK immunoprecipitates (lane 4). In
contrast, the phosphatase untreated mitotic FAK (lane 3)
showed reduced binding to CAS. Quantitative analyses re-
vealed that the binding of CAS to dephosphorylated FAK
is more than three times higher than for untreated FAK
(Fig. 4 b).
The reassociation of FAK with CAS is not due to selec-
tive tyrosine rephosphorylation of FAK during incubation
with interphase extracts. Immunoblot analyses revealed
that the FAK samples, either with or without incubation
with interphase extracts, or with or without prior PP1
treatment, showed almost no reactivity to PY20 (third
panel, Fig. 4; compare with the reactivity of interphase
FAK, lane 4). Quantitative analyses confirmed that the
phosphotyrosine levels of all FAK samples were as low as
mitotic FAK (Fig. 4 b). We also examined whether the
FAK samples showed any difference in the binding to the
SH2 domain of chick Src. It seemed possible that PY20
might not detect a specific phosphotyrosine site, such as
phosphorylation at Tyr-397 of FAK (the Src SH2 domain
is known to bind to FAK phosphorylated at Tyr-397). It
was found that the SH2 domain of chick Src showed an
equally low binding to all FAK samples, suggesting that
differential phosphorylation at Tyr-397 did not occur dur-
ing incubation with interphase extracts (data not shown).
We conclude that mitosis-specific serine phosphorylation
of FAK, but not tyrosine dephosphorylation, is responsi-
ble for the disruption of the FAK/CAS association.
Unlike the FAK/CAS binding, the association between
FAK and c-Src was not reconstituted by serine dephos-
phorylation of FAK. The antiÐc-Src antibody could not
detect c-Src in any of the FAK preparations (data not
shown). These results suggest that near complete tyrosine
dephosphorylation observed during mitosis is likely to be
involved in the FAK/c-Src dissociation, and that the low
level tyrosine phosphorylation seen in trypsinized cells is
responsible for the retained FAK/c-Src association.
 
Mitotic FAK Shows Reduced Binding to the 
Cytoplasmic Domain of Integrin Beta Subunit
 
Both FAK and paxillin have been reported to bind di-
Figure 5. Reduced binding of
mitotic FAK to a peptide mim-
icking the cytoplasmic domain of
integrin beta subunit. (a) Total
cell lysates were prepared from
trypsinized (lane T), mitotic
(lane M), and interphase (lane I)
cells, and were immunoblotted
with the anti-FAK antibody to
confirm that they contain ap-
proximately equal amounts of
FAK. SP-1 peptideÐconjugated
Sepharose beads were incubated
with diluted (93) extracts of
trypsinized (lane T), mitotic
(lane M), and interphase (lane I)
cells. After extensive washing,
bound fractions were analyzed
by SDS-PAGE, followed by im-
munoblotting with the anti-FAK
antibody. (b) Quantitative analy-
ses of SP1 binding. The extracts from trypsinized (T), mitotic (M), and interphase (I) were serially diluted as indicated and bound FAK
was determined by densitometry of immunoblots using the FAK antibody. The levels of bound FAK were expressed as ratios to the
level of bound FAK after incubation with 93 diluted interphase extracts. 
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rectly to a peptide (SP1) representing a membrane-proxi-
mal region of the cytoplasmic domain of the beta subunit
of integrin (Schaller et al., 1995). We examined whether
mitotic FAK or paxillin exhibited altered binding to the
SP1 peptide. SP1 peptideÐconjugated beads were incu-
bated in varying concentrations of extracts prepared from
mitotic, interphase, and trypsinized cells. After washing,
levels of bound FAK and paxillin were detected by immu-
noblotting. As Fig. 5 a shows, mitotic FAK bound to SP1
peptideÐconjugated beads less (lane M) than FAK from
interphase (lane I), or trypsinized (lane T) cells. Quantita-
tive analysis (Fig. 5 b) revealed the binding of mitotic FAK
is 24Ð33% of the level shown by interphase FAK, while
FAK from trypsinized cells showed 65Ð85% binding of the
interphase level (Fig. 5 b). The binding of paxillin to SP1
beads, in contrast, revealed no difference between mitotic
and interphase cells (data not shown).
 
Reversal of Mitosis-specific Phosphorylation during 
Post-mitotic Cell Spreading
 
We examined at which stages of cell division mitosis-spe-
cific phosphorylation reversed, because such information
would be useful to conceive the physiological roles of
mitosis-specific phosphorylation. Nocodazole-arrested mi-
totic cells were collected and released to allow entry into
G1, and total cell lysates were prepared at different stages
of metaphase-G1 transition. The mobilities of FAK, CAS,
and paxillin were analyzed by immunoblotting. As Fig. 6
shows, the mobility shifts of FAK, CAS, and paxillin con-
tinue for 80Ð120 min after the release of metaphase arrest,
with FAK exhibiting the fastest recovery. At 120 min FAK
Figure 6. Reversal of mobility shifts of FAK, CAS, and paxillin
(PAX) during post-mitotic cell spreading. Mobility shifts were
examined by immunoblotting of total cell lysates prepared from
interphase (I) or mitotic (M) cells, or cells released from mitotic
arrest (numbered lanes, n 5 min removed from nocodazole). To-
tal cell lysates were blotted on PVDF membranes, and the mem-
branes were probed with the antibodies against CAS, FAK, pax-
illin, or cyclin B, as indicated. Cyclin B1 immunoblot is shown as
an indicator of metaphaseÐanaphase transition. Note that CAS,
FAK, and paxillin show reversal of mobility shifts during 80Ð180
min after the release of mitotic arrest, a time span corresponding
to post-mitotic cell spreading.
 
mobility appeared normal, while significant amounts of
paxillin and CAS still retained slower mobilities. It should
be noted that this time point (120 min) corresponded to
post-mitotic cell spreading, long after cytokinesis (which
occurred during 40Ð60 min). MetaphaseÐanaphase transi-
tion was confirmed by a cyclin B immunoblot. The cyclin
B band started to disappear at 40 min (Fig. 6).
Because tyrosine phosphorylation plays an important
role in signal transduction and organization of focal adhe-
sions, the time course of tyrosine rephosphorylation was
also examined. Immunoprecipitates of FAK, paxillin, and
CAS prepared at different stages of cell cycle were blotted
with PY20, and reprobed with the antibodies against each
protein for normalization. As Fig. 7 shows, the proteins
were tyrosine rephosphorylated between 80 and 180 min
after release of mitotic arrest (corresponding to post-
mitotic cell spreading). FAK exhibited the fastest kinetics
of tyrosine rephosphorylation and the largest increase in
tyrosine phosphorylation at 180 min. The PY20 reactivity
of FAK was increased threefold between 80 and 180 min,
while paxillin gradually increased only 134%. CAS showed
the slowest tyrosine rephosphorylation, the PY20 reactiv-
ity of CAS was 
 
,
 
15% of the interphase level, even at 120
min. In the next 1 h, however, the PY20 reactivity of CAS
increased to 200%.
The increase in tyrosine phosphorylation of FAK during
post-mitotic cell spreading resulted in marked activation
of FAK-associated tyrosine kinase activity. We measured
tyrosine kinase activity associated with FAK immunopre-
cipitates in different stages of the cell cycle (condition I
was used to prepare FAK free from associated c-Src or
CAS). The activity of FAK toward poly (Glu/Tyr) at 180
min was twice as high as interphase FAK, while the activ-
ity of mitotic FAK was 10 times less than interphase FAK
(data not shown). The results are consistent with the re-
port that the enzymatic activity of FAK depends on its
level of tyrosine phosphorylation (Calalb et al., 1995).
 
Discussion
 
We have demonstrated that FAK undergoes mitosis-spe-
cific, serine phosphorylation simultaneously with tyrosine
dephosphorylation; during mitosis a FAK/CAS/c-Src com-
plex is dissociated; and mitosis-specific serine phosphory-
lation of FAK causes the dissociation of FAK/CAS com-
plex while tyrosine dephosphorylation appears to disrupt
FAK/c-Src association.
 
Mechanisms for Dissociation of a FAK/CAS/c-Src 
Complex during Mitosis
 
FAK binds directly to the SH3 domain of CAS via proline-
rich domains of FAK (Polte and Hanks, 1995, 1997; Harte
et al., 1996). It is likely the mitosis-specific serine phosphor-
ylation alters such interactions. It is interesting to note that
one of the proline-rich domains contains serine, and it may
be possible that phosphorylation would occur at this serine,
reducing the interaction between FAK and CAS.
The association of c-Src with FAK or CAS, on the other
hand, has been reported to depend on the binding be-
tween phosphotyrosine of FAK or CAS and the SH2 do-
main of c-Src (Schaller et al., 1994; Xing et al., 1994; Eide 
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et al., 1995; Nakamoto et al., 1996; Schlaepfer et al., 1997).
However, FAK from trypsinized cells retains a high level
of association of c-Src. It seems likely that the residual ty-
rosine phosphorylation of FAK in trypsinized cells may be
able to preserve the association between FAK and c-Src.
Furthermore, a recent report has shown, in addition to the
SH2-binding site, FAK has a Src SH3-binding site (Tho-
mas et al., 1998). This SH3-mediated interaction could re-
inforce the retained association between FAK and c-Src in
trypsinized cells.
 
Reduced Binding of Mitotic FAK to the Cytoplasmic 
Domain of Integrin Beta Subunit
 
The NH
 
2
 
-terminal noncatalytic domain of FAK was re-
ported to be responsible for its binding to SP1 beads
(Schaller et al., 1995). It is worthy to note that this domain
does not contain tyrosine phosphorylation sites. Because
FAK from both trypsinized and mitotic cells showed low
tyrosine phosphorylation, it seems likely that mitosis-spe-
cific phosphorylation of FAK is involved in the reduced
binding to the cytoplasmic domain of integrin beta sub-
unit. At present, we cannot directly examine the effects of
serine dephosphorylation of mitotic FAK on the binding
to SP1 beads because purification of mitotic FAK has
been unsuccessful. Therefore, we cannot exclude a possi-
bility that tyrosine dephosphorylation is involved in the
loss of FAK to SP1 beads.
 
Mitosis-specific Phosphorylation of CAS and Paxillin
 
We have demonstrated that CAS and paxillin, like FAK,
show mitosis-specific serine phosphorylation. Currently,
we do not know the functional consequence of the serine/
threonine phosphorylation of CAS or paxillin. CAS, either
from interphase or mitotic cells, does not bind to mitotic
FAK (Figs. 3 and 4). This suggests that mitosis-specific
phosphorylation of CAS does not seem to be essential for
the dissociation between CAS and FAK, although it is
possible that phosphorylation of CAS further decreases
the binding between FAK and CAS. In addition, the asso-
ciation of paxillin with FAK is not disturbed during mito-
sis. Both paxillin and CAS function as docking proteins. It
is possible that mitosis-specific phosphorylation would dis-
rupt the association with other proteins, which may con-
tribute to the phenotypic alterations seen during mitosis.
One interesting possibility would be mitosis-specific phos-
phorylation of CAS inhibiting cell motility of mitotic cells.
 
Physiological Significance of the Disruption of
FAK/CAS/c-Src Complexes
 
First, the disruption of FAK/CAS association during mito-
sis is likely to result in uncoupling of the FAK- and CAS-
mediated signal transduction during mitosis. The reduced
binding of mitotic FAK to the cytoplasmic domain of inte-
grin beta subunit (Fig. 5) would amplify the uncoupling ef-
fects by altering the interactions between ECM and focal
adhesions. Further, the dissociation of the FAK/CAS/c-Src
complex could abolish FAK-mediated c-Src activation dur-
ing mitosis because the association of CAS or FAK with
c-Src has been suggested to activate Src by displacing the
inhibitory tail domain of Src from its catalytic domain
Figure 7. Tyrosine rephosphorylation of FAK (a), paxillin (b),
and CAS (c) during post-mitotic cell spreading. FAK, CAS, and
paxillin were immunoprecipitated from interphase cells (I), mi-
totic cells (M), and cells released from mitotic arrest (numbered
lanes, n 5 min removed from nocodazole). The immunoprecipi-
tates were transferred to PVDF membranes, first immunoblotted
with PY20, then reprobed with the antibodies against FAK, pax-
illin, and CAS. The levels of phosphotyrosine are shown by ratios
(100% for interphase level) of the levels of PY20 reactivities di-
vided by the levels of FAK, paxillin, or CAS. Note that FAK ex-
hibits the fastest recovery of tyrosine rephosphorylation as well
as the greatest increase in tyrosine phosphorylation during 80Ð
180 min after the release of mitotic arrest. 
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(Hanks and Polte, 1997). Src has been reported to be acti-
vated during mitosis by dephosphorylation at Tyr-527 of
the tail domain (Bagrodia et al., 1991; Shalloway et al.,
1992), which appeared to be inconsistent with the above
notion. However, the mitotic activation of Src occurs inde-
pendently of FAK since FAK is neither tyrosine phosphor-
ylated nor associated with Src during mitosis. A substrate
of mitotic Src, sam68, does not seem to be involved in
FAK-mediated signal transduction (Fumagalli et al., 1994;
Taylor and Shalloway, 1994; Taylor et al., 1995).
Second, the uncoupling probably represents an ÒoffÓ
state of the FAK-mediated signaling pathway of mitotic
cells, and this off state would be required for mitotic cells
to switch ÒonÓ the signal transduction pathway at later
stages of cell cycle. For proliferation, normal adherent cells
must attach to a substrate during early G1 (OÕNeill et al.,
1986; Lo and Chen, 1994), at which time FAK-mediated
signaling is believed to occur. The mitotic inactivation of
FAK would thus act to reestablish the requirement of ad-
hesion for the next round of cell cycle progression.
Third, the inactivation of FAK may contribute to the in-
hibition of cell spreading and/or cell migration in mitosis.
FAK has been implicated to play roles in cell spreading
(Richardson and Parsons, 1996; Richardson et al., 1997)
and in cell migration (Cary et al., 1996; Gilmore and
Romer, 1996). The disruption of FAK/CAS/c-Src complex
during mitosis could be a mechanism for the inhibition of
cell migration during mitosis because the FAK/CAS or
CAS/Crk association has been shown to be important for
cell migration by FAK (Cary et al., 1998; Klemke et al.,
1998).
Mitosis-specific phosphorylation of FAK could block
RhoA-mediated activation of FAK during cytokinesis. It
has been reported that the activation of RhoA is required
for the completion of cytokinesis because botulinum C3
exoenzyme (which inhibits Rho specifically) blocks cytoki-
nesis (Kishi et al., 1993; Mabuchi et al., 1993). Activation
of RhoA, on the other hand, is also known to occur upon
serum stimulation of 3T3 fibroblasts, which induces the
formation of both stress fibers and focal adhesions (Ridley
and Hall, 1992, 1994; Ridley, 1995) as well as tyrosine
phosphorylation of FAK (Seufferlein and Rozengurt,
1994a,b, 1995). FAK phosphorylation is blocked by botuli-
num C3 exoenzyme (Rankin et al., 1994), placing FAK
downstream of RhoA. Mitotic cells should have a mecha-
nism that suppresses RhoÕs ability to activate FAK, and
mitosis-specific phosphorylation of FAK may be involved
in such a mechanism. FAK phosphorylation continues
through cytokinesis, and the reversal of the modification
occurs during post-mitotic cell spreading (Fig. 6). FAK
phosphorylation may act as an internal clock by prevent-
ing premature activation of FAK during cytokinesis. The
lack of such phosphorylation in trypsinized cells would ex-
plain the rapid adhesion shown when they are plated on
ECM-coated substrates.
The mitosis-specific modification of FAK, CAS, and
paxillin is apparently a general phenomenon. We have ob-
served similar mobility shifts with other types of adherent
cultured cells including 3T3 and HeLa cells. A similar mo-
bility shift has been reported for paxillin (Yamaguchi et al.,
1997). We are in the process of identifying kinase(s) and
phosphatase(s) responsible for the alterations in the phos-
phorylation states of these proteins. Cdc2 kinase is not re-
sponsible for the mitosis-specific phosphorylation (our un-
published data), which is consistent with the time course of
phosphorylation, i.e., phosphorylation continues past cy-
tokinesis. The identification and characterization of ki-
nase(s) and phosphatase(s) would help us understand the
mechanisms that define the timing of mitotic events in-
cluding cell rounding during prophase, cytokinesis, and
post-mitotic cell spreading.
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